Information from Industry - Sponsored Supplement

Omadacycline: An Oral Antibiotic for the Treatment of Bacterial Skin Infections and Pneumonia in an Era of Unmet Clinical Need

The Journal of Family Practice. 2022 June;71(5):
This supplement was sponsored by Paratek Pharmaceuticals, Inc. It was edited and peer reviewed by The Journal of Family Practice.
June 6, 2022|Family Medicine

Despite advances in the management of skin and soft tissue infections and community-acquired pneumonia, challenges persist. This 2-part supplement to The Journal of Family Practice summarizes the findings of 3 phase 3 studies of omadacycline.
 

Read More

 

,false